Latest News
CSX: 3 Key Takeaways for Long-Term Investorsfool.com
Pricing discipline and operational efficiency are compounding faster than cost inflation, a rare mix that protects long-term returns.
Via The Motley Fool · October 21, 2026
Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching.fool.com
What would it take for these six next-generation tech stocks to double?
Via The Motley Fool · October 21, 2026
Lam Research: 3 Key Takeaways for Long-Term Investorsfool.com
Three structural shifts in chip design are forcing semiconductor makers to order significantly more manufacturing equipment.
Via The Motley Fool · October 21, 2026
2 Insurance Stocks to Buy That Keep About 16 Cents of Every Premium Dollar as Underwriting Profitfool.com
Although neither Travelers nor Chubb is cheap today, strong operating results may interest growth-minded investors.
Via The Motley Fool · October 21, 2026
Meta: 3 Key Takeaways for Long-Term Investorsfool.com
Lower unit costs from AI-powered content processing are strengthening profit margins as engagement scales across Meta's social platforms.
Via The Motley Fool · October 21, 2026
Amazon vs. Target: Where Should Long-Term Investors Put Their Money?fool.com
Amazon's operating cash flow towers over Target, but valuation multiples tell a different story.
Via The Motley Fool · October 21, 2026
Centrus vs. BWX Technologies: Which Nuclear Supply Chain Stock Is the Better Buy After the Sell-Off?fool.com
Nuclear power is in the spotlight, but these two stocks have tumbled over the past year. Here's which sold-off stock is a better buy right now.
Via The Motley Fool · October 21, 2026
Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advancesmarketbeat.com
Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional milestones from its collaboration with Chugai.
Chief Executive Officer Talat Imran said the clinical-stage biotechnology
Via MarketBeat · October 21, 2026
IBM: 3 Key Takeaways for Long-Term Investorsfool.com
Structural cost discipline is lifting margins even as the company invests in growth, a dynamic that underpins confidence in accelerating free cash flow.
Via The Motley Fool · October 21, 2026
Arista Networks vs. CrowdStrike: Which Tech Stock Is a Better Buy in 2026?fool.com
Arista boasts a high profit margin and zero debt, while CrowdStrike just reported its best quarter in history because of AI.
Via The Motley Fool · October 21, 2026
Telus Dividend Reliability: Is the Telecom Still Worth Holding?fool.ca
Telus (TSX:T) stock might be a falling knife, but the shares still look like a dividend deal going into November 2026.
Via The Motley Fool · October 21, 2026
I Keep Coming Back to This 5.6% Dividend Stockfool.ca
Brookfield Renewable offers a 5.6% yield and targets 10%+ FFO growth. Here is what management said, plus risks every Canadian income investor should weigh.
Via The Motley Fool · October 21, 2026
NVE (NVEC) Q2 2027 Earnings Call Transcriptfool.com
Defense sales plunged 95%, but first-half revenue surged 36% on distributor strength.
Via The Motley Fool · October 21, 2026
Cathay General Bancorp (CATY) Q3 2026 Earnings Call Transcriptfool.com
Record net interest income and expanded margins drove sequential earnings growth.
Via The Motley Fool · October 21, 2026
QuantumScape (QS) Q3 2026 Earnings Call Transcriptfool.com
Solid-state battery maker launches 100 MWh mass production line targeting 2028.
Via The Motley Fool · October 21, 2026
WD-40: 3 Key Takeaways for Long-Term Investorsfool.com
Gross margins dipped to 52.8%, but management expects recovery within two quarters as pricing actions take hold.
Via The Motley Fool · October 21, 2026
I Split $20,000 Across 3 TSX Stocks for $715 a Year in Passive Income: Here Are the Picksfool.ca
With their reliable cash flows, consistent dividend growth, and strong long-term growth prospects, these three TSX stocks could help investors build a sustainable stream of passive income.
Via The Motley Fool · October 21, 2026
A Tailor-Made TFSA Stock: An 8.3% Yield With Monthly Paychequesfool.ca
A non-bank lender paying monthly dividends, including year-end special dividends, is tailor-made for a TFSA.
Via The Motley Fool · October 21, 2026
Ategrity (ASIC) Q3 2026 Earnings Call Transcriptfool.com
Record combined ratio of 84.7% and 30% submission growth signal strong underwriting momentum.
Via The Motley Fool · October 21, 2026
Knight-Swift (KNX) Q3 2026 Earnings Call Transcriptfool.com
Truckload margins recovered as pricing gains and efficiency improved operating ratio 450 basis points.
Via The Motley Fool · October 21, 2026
SAP (SAP) Q3 2026 Earnings Call Transcriptfool.com
Cloud revenue surged 25% as AI adoption drove productivity gains across enterprise software.
Via The Motley Fool · October 21, 2026
Philip Morris: 3 Key Takeaways for Long-Term Investorsfool.com
The company is sacrificing near-term margins to defend its nicotine pouch dominance while traditional cigarettes fund the shift.
Via The Motley Fool · October 21, 2026
Rocket Lab Stock Plunged After a New Neutron Setback: What This Delay Really Means for Investorsfool.com
Rocket Lab's Neutron setback forces investors to reassess launch timelines and valuation.
Via The Motley Fool · October 21, 2026
Here’s Why I Love Freehold Royalties (and Its Generous 6.1% Dividend Yield)fool.ca
Here’s why Freehold’s royalty business, generous monthly dividend and room for long-term growth make it one of my favourite Canadian stocks.
Via The Motley Fool · October 21, 2026
CN Stock Looks Like a Buy After Raising Its 2026 Outlookfool.ca
CN stock has a stronger 2026 outlook and a 2.2% dividend yield. Here’s what supports the buying case and what investors should watch.
Via The Motley Fool · October 21, 2026
